A new digital media service will foster the global collaboration of physicians and help them to share the latest advances in AIDS and other virus research, according to its Canadian promoters.
The new bilingual French and English service, “viroXchange,” is funded by large pharmaceutical companies but will provide “independent” reporting on the latest medical breakthroughs for healthcare professionals, they said.
“ViroXchange broadens access to information by researchers in general, while allowing them to share their knowledge on a global scale,” Dr Mark Wainberg, a member of the initiative’s Scientific Committee, said in a statement.
“It’s important for the scientific community to be aware of the latest trials and of their impact on research priorities and scenarios. In this context, viroXchange allows us to better collaborate.”
The digital service, unveiled at an annual HIV/AIDS conference held here in Montreal, will mainly produce online videos, said Guy-Charles Pelletier, CEO of the Neuhauz company and architect of the project.
A team of reporters will cover the 10 major scientific conferences each year, interviewing specialists on camera about the latest studies and advances in HIV/AIDS and Hepatitis C research, he said.
The videos will then be edited by a team led by Dr Rejean Thomas, a leading figure in the fight against AIDS in Quebec and head of the largest specialized clinic in the province, in consultation with the Scientific Committee.
The target audience is doctors and other healthcare specialists, especially those working in AIDS-ravaged Africa and elsewhere in the developing world, who cannot afford to attend several international conferences each year.
It will also be geared towards specialists who want to stay up to date on the latest findings but do not always have time to leaf through major journals, organizers say.
The company will begin with just 20 employees, 10 of them permanent, but Pelletier hopes to expand the staff to 100 within the next three years, creating what he calls the “CNN of virology.”
Trump lawyer cites former GOP senator to discredit impeachment — but leaves out he supports convicting the president
During the Senate impeachment trial on Monday, White House lawyer Robert Ray attempted to contrast the impeachment of President Donald Trump with that of President Richard Nixon, by arguing that unlike in the former case, Republicans came together with Democrats to call for removing Nixon. As part of the comparison, he brought up then-Rep. William Cohen, who went on to become a U.S. senator from Maine and Secretary of Defense for President Bill Clinton.
"Together these six Republicans made history," said Ray. "They did so with no sense of triumph and no fist bumps."
What Ray chose not to mention, however, is that Cohen has specifically weighed in on the Trump case, and said that he should be impeached and removed over the Ukraine scheme.
There are 51 votes to approve calling witnesses in Trump impeachment trial: PBS
After pieces of John Bolton's manuscript leaked to the press confirming President Donald Trump's bribery of Ukraine, Republicans have turned to support the witnesses they once opposed.
Sens. Mitt Romney (R-UT) and Susan Collins (R-ME) both voted against witnesses and were leaning against them until Bolton's manuscript was leaked to the press after it was turned over to the White House for approval.
PBS News Hour reporter Lisa Desjardins tweeted Monday evening that the news tipped the scales and there were officially 51 votes to approve witnesses.
‘Give me a break’: CNN analyst explains why Trump defense of Rudy Giuliani was terrible
While the Senate impeachment trial against President Donald Trump paused for a dinner break, CNN analysts responded to the White House's afternoon defense of the president was by blaming the Biden family.
Political commentator Gloria Borger noted that Trump lawyer, Eric Herschmann, going after former President Barack Obama just seemed desperate.
"Give me a break," she said. "What does that have to do with any of this right now? His defense boiled down to, 'He did it, so what? He did it. He was trying to root out corruption.' But if he was concerned about rooting out corruption, why haven't we seen more of that? His defense was, 'He had a reason to do it. It's OK. Therefore it was in the national interest.' This wasn't just about Joe Biden."